quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:00:37·44d
SECFiling
Lixte Biotechnology Holdings Inc. logo

Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

LIXT· Lixte Biotechnology Holdings Inc.
Health Care
Original source

Companies

  • LIXT
    Lixte Biotechnology Holdings Inc.
    Health Care

Related

  • INSIDER6d
    SEC Form 4 filed by Felix Lourdes
  • INSIDER6d
    SEC Form 4 filed by Pursglove Geordan Garrett
  • INSIDER6d
    SEC Form 4 filed by Stazzone Peter
  • INSIDER6d
    SEC Form 4 filed by Sawyer Jason David
  • INSIDER6d
    SEC Form 4 filed by Holloway Michael Andrew
  • INSIDER6d
    SEC Form 4 filed by Primus Guy Warren
  • SEC6d
    Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • PR10d
    Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022